The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
about
Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver diseaseEpidemiological link between low cholesterol and suicidality: a puzzle never finished.Metabolic, digestive, and reproductive adverse events associated with antimanic treatment in children and adolescents: a retrospective cohort study.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in RatsComparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression.Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes.Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerabilityAdverse reactions to duloxetine in depression.Metabolic syndrome and major depression.High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.Tricyclic and SSRI usage influences the association between BMI and health risk factors.Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: a prospective naturalistic study.Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder.Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice
P2860
Q27012600-29E310BA-C947-47DC-8655-092D22A82DF2Q33352441-F4FE9970-BEC9-496D-8FFB-05A70C672B03Q34318121-1EA65C56-4CF5-4407-AD07-97A08F9B7BA7Q35754726-AE591F9F-B473-4DEC-B3A8-34DD1254D90FQ36176479-D249897B-AFCA-4D27-8797-246A7CCA7E41Q36565050-A426B162-0545-4534-A6D3-F2ADB02014ABQ37384427-40700111-54DB-4EFA-A8CD-AEFF47B9372AQ37429825-89FCC649-3F54-45A5-BDED-3C4436CA5F34Q37872294-FD07396E-0367-4EF8-809A-B10FFA02435DQ38150605-3F9C1BB3-BC35-4484-B8CE-80665BF08340Q41313523-12013CCC-9C57-4AD9-AEBF-77A9F10415E6Q42322887-9B6F27D0-EB76-4374-8F25-20F244A4809FQ48086957-B4200091-CE40-447C-A646-7EE0C1F5D038Q50072228-97759EAD-05F7-46C7-903D-0E50A8AB80BFQ50778364-D5AEEA56-1E8A-4E78-AABF-4186CC727566Q51854870-AD195943-8E2F-4745-B8D7-BD7C7C12CDF6Q59138300-7E6F8FCF-97F3-48DE-9A4A-31A0B741323F
P2860
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@ast
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@en
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@nl
type
label
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@ast
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@en
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@nl
prefLabel
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@ast
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@en
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@nl
P2860
P356
P1476
The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
@en
P2093
Jakub Z Konarski
Roger S McIntyre
P2860
P304
P356
10.1517/14740338.5.4.523
P407
P577
2006-07-01T00:00:00Z